All Companies

ABT

Abbott Laboratories

Pharmaceutical Preparations

$102.61updated Sep 19, 2026

Congressional trading profile for Abbott Laboratories (ABT), covering 49 disclosed transactions by 19 lawmakers.

Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.

Total Trades

49

Politicians Trading

19

Last Traded

Jul 30, 2026

Price history

Congressional Trades

PoliticianNotifiedTradedTypeAmountChange
Rick W. AllenRAug 18, 2026Jul 14, 2026Sell$15,001 - $50,000+15.34%
Richard McCormickRAug 14, 2026Jul 30, 2026Sell$1,001 - $15,000-2.84%
Mike KellyRAug 12, 2026Jul 17, 2026Sell$1,001 - $15,000+1.92%
Alan ArmstrongRJul 21, 2026Mar 27, 2026Sell$15,001 - $50,000-1.33%
Julia LetlowRJan 13, 2026Dec 8, 2025Sell$1,001 - $15,000-15.96%
Byron DonaldsRJan 7, 2026Dec 4, 2025Sell$1,001 - $15,000-18.17%
Byron DonaldsRJan 7, 2026Dec 4, 2025Sell$1,001 - $15,000-18.17%
Lisa C. McClainRAug 13, 2025Jul 10, 2025Sell$1,001 - $15,000-23.20%
Jefferson ShreveRJun 22, 2025May 12, 2025Sell$50,001 - $100,000-22.26%
Bruce WestermanRMay 12, 2025Apr 21, 2025Sell$1,001 - $15,000-21.00%
Shelley Moore CapitoRMar 6, 2025Feb 24, 2025Sell$1,001 - $15,000-23.96%
Markwayne MullinRJan 31, 2025Jan 8, 2025Sell$1,001 - $15,000-10.19%